ABSTRACT
7 6
Sequence Read Archive (BioProject accession number PRJNA234047). Sequences corresponding to the HIV-1 and CMV controls in the PC and the MS2 (RNA) phage and T1 sequencing runs for the study were performed by state-licensed clinical laboratory scientists.
8 7
For each sequencing run, NTC ("no template" control), PC (positive control), and up to 8 patient sequence data were analyzed using SURPI+, a bioinformatics analysis pipeline for pathogen use. Specifically, the SURPI+ pipeline included filtering algorithms for exclusion of false- identification, automated report generation implementing a priori established thresholds for pathogen detection, and a web-based graphical user interface to facilitate laboratory director NTC sample that were potential background contaminants. Viruses comprising known flora, parasites, we developed a reads per million (RPM) ratio metric, or RPM-r, defined as RPM-r = 2 0 8 RPM sample / RPM NTC (with the minimum RPM NTC set to 1). This metric accounted for background 2 0 9 9 contamination by normalizing the RPM of detected pathogen reads assigned to a given 2 1 0 taxonomic classification (family, genus, or species) with respect to the RPM in the NTC. To 2 1 1 determine the optimal threshold value for RPM-r, we plotted receiver operating characteristic 2 1 2 (ROC) curves at varying ratios corresponding to mNGS analysis of 95 clinical CSF samples that 2 1 3 were included in the accuracy evaluation (Supplemental Figure S3 ; also see below). The 2 1 4 ROC curve analysis showed that an RPM-r of 10 maximized accuracy for organism detection. Thus, we designated a minimum threshold of 10 RPM-r for reporting the detection of a and/or skin flora were detected in a CSF sample above the 10 RPM-r threshold, and attributed 2 1 8 to contamination. In these cases (n=7), mNGS results were reported as "multiple bacterial 2 1 9 genera detected" (with an interpretive comment indicating likely sample contamination), and 2 2 0 were considered as negative for bacterial detection by mNGS. To calculate the 95% limits of detection (LOD), defined as the lowest concentration at the estimated detection limit were tested by mNGS. Using probit analysis, a 95% limit of 2 2 6 detection was determined for each of the 7 representative organisms in the PC ( final working PC consisted of the 7 organisms spiked at concentrations ranging from 0.5-2 log .09856-.09996) (Supplemental Figure S4 ). We demonstrated inter-assay reproducibility by mNGS testing of the NTC and PC had fewer than the minimum designated cutoff of 5 million reads. All 7 organisms were detected 2 4 0 using pre-established threshold criteria for the intra-assay run and each replicate inter-assay run 2 4 1 ( Supplemental Table S1 ).
5 1
Overall, the mNGS assay showed 73% sensitivity and 99% specificity compared to fungi (diagnosed by culture and/or antigen testing) (Supplemental Table S1 ). One mNGS
result was considered to be false-positive for Bacillus sp. detection in a culture-negative CSF.
5 7
All 5 organisms spiked into negative CSF matrix as part of the accuracy study were correctly Discrepancy analysis using targeted clinical PCR was performed on 18 samples with EBV, 1 HSV, 1 HHV6). In 8 cases, mNGS results were initially considered to be false negatives 2 6 3 but enough sample was available for discrepancy testing using molecular methods. Overall, (1 case also had cross-reactive IgM antibodies to Japanese Encephalits Virus (JEV) in blood)
were negative by WNV PCR testing, concordant with the mNGS results. Two culture-positive 2 6 8 bacterial cases with negative mNGS results underwent orthogonal testing using 16S rRNA 2 6 9
bacterial PCR, and one was not detected (P. mirabilis), whereas one was positive (E.
galinarum). Four culture-positive samples with negative mNGS results for fungi were tested 2 7 1 using 18S internal transcribed spacer (ITS) PCR, and 2 were negative (C. parapsilosis and C. neoformans) whereas the other 2 were positive (A. fumigatus and S. schenkii).
7 3
Among the 3 remaining bona fide false-negative mNGS cases (E. galinarum, A. fumigatus, and S. schenkii), the first 2 cases were only weakly positive by original clinical testing 2 7 5
(the E. galinarum grew from broth only, whereas the A. fumigatus was galactomannan-positive
and fungal culture negative). Both were also high-background samples (Supplemental Table   2 7 7 S1), and thus the number of identified pathogen reads did not meet thresholds for reporting. The third case (S. schenckii) was likely missed by mNGS testing because the ~32 Mb genome of S. have been recovered in CSF cultures, the presence of these organisms could not be
independently confirmed by molecular testing and thus these mNGS results were excluded from 2 9 1 the comparisons, as it could not be determined whether a given additional detection was a true 2 9 2 or false positive. IC RPM of <100, indicating potential decreased sensitivity for the mNGS assay due to high (1 RNA virus, 3 DNA virus, 19 bacteria, 2 fungi, 1 negative), and exclusion of these yielded 91%
positive percent agreement and 99% negative percent agreement for the mNGS assay overall. We evaluated the effects of interference with human DNA and RNA, red blood cell Staphylococcus epidermidis) on mNGS assay performance (Table 1) . Addition of human DNA found to be linearly correlated with the amount of added exogenous DNA (R 2 = 0.999). Based background (Supplemental Figure S5) . For mNGS reporting, these high-background samples Gross hemolysis (dark red CSF) resulted in decreased sensitivity for RNA virus detection (HIV-1 in the PC) by mNGS, but did not affect detection sensitivity for DNA pathogens. Moderate to low levels of hemolysis (pink to light red CSF) did not affect detect sensitivity for within the same genus when mixed at 1:1, 4:1, and 1:4 ratios, as both species were correctly 3 2 7
identified and calculated RPM-r values were within 7% of that expected on the basis of the 3 2 8 spiked amounts. Analysis of replicates of the PC held at 4°C for 0, 2, 5, and 6 days and subjected to 3
freeze-thaw cycles demonstrated detection of all organisms (Table 1) .
Challenge study
We blindly evaluated the performance of the mNGS assay on a set of 20 prospectively encephalitis, and/or myelitis (Supplemental Table S2 ). Comparison of the results assembled comparison due to the lack of confirmatory testing from CSF. In addition, mNGS failed to detect testing, including 1 case of culture-negative, presumptive bacterial meningitis and 3 cases of 3 5 7 idiopathic encephalitis. Here we developed and validated a clinical mNGS assay intended to diagnose infectious 3 6 1 etiologies of meningitis, encephalitis, and myelitis from CSF, followed by blinded evaluation of 3 6 2 mNGS performance using a set of 20 prospectively collected CSF samples from pediatric patients admitted to a tertiary care hospital. As CSF is considered a normally sterile site, we postulated that mNGS data generated from testing of this body fluid type would be more
straightforward to interpret than data from more "environmental" samples such as respiratory 3 6 6 secretions and stool. However, numerous challenges had to be overcome for successful incorporating two PCR steps, an initial step for library amplification and a recovery amplification step to ensure robust library construction from relatively acellular CSF samples or the NTC 3 7 2 buffer control, both containing little to no human host background. Second, the mNGS assay
had to be capable of simultaneously detecting a broad spectrum of pathogens, including viruses
(both single-and double-stranded RNA and DNA genomes), bacteria, fungi, and parasites.
Thus, the mNGS protocol incorporated (1) a bead-beating step for lysis of microbial cell walls,
(2) separate construction of RNA and DNA libraries from nucleic acid extracts for detection of RNA viruses and DNA pathogens, respectively, and (3) bioinformatics analysis using the reproducible threshold metrics needed to be developed and evaluated using ROC curve
analysis to enable correct identification of pathogens from mNGS data above background noise.
We developed quality control materials and metrics for the CSF mNGS assay, including for infectious disease diagnostics is background interference, generally from human host DNA. The use of a spiked phage IC was found to be useful for assessing whether high background testing approaches such as PCR and mNGS may be inappropriate and there should be a low to physicians, potentially informing the next steps in diagnosis, management, and treatment of 4 6 7 the patient, and may also prove informative for public health surveillance and outbreak O v e r a l l 7 3 9 9 8 1 9 9 9 1 9 9
Abbreviations: PC, positive control mix of 7 representative organisms; IC, spiked internal control consisting of a DNA T1 phage and RNA M2 phage; mNGS, metagenomic next-generation sequencing; QC, quality control; Sens, sensitivity; Spec, specificity; PPA, positive percent agreement; NPA, negative percent agreement a Pre-designated QC thresholds included >5 million reads per library, >100 RPM for the spiked ICs, >3 nonoverlapping gene regions for the viruses in the PC, and >10 RPM for the non-viral pathogens in the PC 100% concordance 
